Q4 2019 Holdings
Filed 2020-02-14 | 135 holdings | $257.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Amarin | ADR | 023111206 | $111.7K | 5,208,305 | 0.0% |
| Karuna Therapeutics, Inc. | COMM | 48576A100 | $142.1K | 1,885,602 | 0.1% |
| Nextcure, Inc | COMM | 65343E108 | $150.5K | 2,671,856 | 0.1% |
| Aclaris Therapeutics(ACRS) | COMM | 00461U105 | $3.6M | 1,911,573 | 1.4% |
| BioCryst Pharmaceuticals Inc(BCRX) | COMM | 09058V103 | $7.4M | 2,151,164 | 2.9% |
| Biogen Inc(BIIB) | COMM | 09062X103 | $18.9M | 63,711 | 7.3% |
| Coherus BioSciences(CHRS) | COMM | 19249H103 | $34.8M | 1,933,221 | 13.5% |
| Biomarin Pharmaceutical Inc(BMRN) | COMM | 09061G101 | $37.4M | 441,872 | 14.5% |
| Ascendis Pharma A/S(ASND) | ADR | 04351P101 | $154.4M | 1,109,874 | 59.9% |